CIPROFLOXACIN

Course overview

CIPROFLOXACIN IS AN ANTIBIOTIC AGENT IN THE FLUOROQUINOLONE CLASS USED TO TREAT BACTERIAL INFECTIONS SUCH AS URINARY TRACT INFECTIONS AND PNEUMONIA. CIPROFLOXACIN HAS FDA APPROVAL FOR THE TREATMENT OF URINARY TRACT INFECTIONS, SEXUALLY TRANSMITTED INFECTIONS (GONORRHEA AND CHANCROID), SKIN, BONE AND JOINT INFECTIONS, PROSTATITIS, TYPHOID FEVER, GASTROINTESTINAL INFECTIONS, LOWER RESPIRATORY TRACT INFECTIONS, ANTHRAX, PLAGUE, AND SALMONELLOSIS. CIPROFLOXACIN IS AN APPROPRIATE TREATMENT OPTION IN PATIENTS WITH MIXED INFECTIONS OR PATIENTS WITH PREDISPOSING FACTORS FOR GRAM-NEGATIVE INFECTIONS. THIS ACTIVITY COVERS CIPROFLOXACIN, WHICH IS A BROAD-SPECTRUM QUINOLONE ANTIBIOTIC THAT MEMBERS OF THE INTERPROFESSIONAL TEAM NEED TO REVIEW ITS INDICATIONS, COVERAGE, CONTRAINDICATIONS, AND ADVERSE EVENT PROFILE TO OPTIMALLY MANAGE PATIENTS WITH INFECTIOUS DISEASE.